[Efficiency of famotidin in NPVP-gastropaty result of multicentered research barrier-1(protection of gastric mucosal from non-steroidal anti-inflammatory drugs] [English Abstract, Journal Article]
Eksp Klin Gastroenterol 2009; (2):3-9.
This article presents results of the first Russian randomized study of NSAID-gastropaty prevention at patients receiving NSAIDS. Results of clinical and endoscopic monitoring of two groups of patients: 1st - 108 patients with AA or RA treated with diclofenac and famotidin and 2nd--116 patients with AA or RA receiving diclofenac treatment only. It was shown that combined use of diclofenac and famotidin reduces to 2.6 times frequency and significantly reduces severity of painful dyspepsia symptoms and antipain manifestations reduces more than twice frequency of erosive-ulcerous lesions of gastric mucosa and duodenum.
More from this journal |
